Literature DB >> 10900007

alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria.

G Gonzalez-Aseguinolaza1, C de Oliveira, M Tomaska, S Hong, O Bruna-Romero, T Nakayama, M Taniguchi, A Bendelac, L Van Kaer, Y Koezuka, M Tsuji.   

Abstract

Natural killer T (NKT) cells are a unique population of lymphocytes that coexpress a semiinvariant T cell and natural killer cell receptors, which are particularly abundant in the liver. To investigate the possible effect of these cells on the development of the liver stages of malaria parasites, a glycolipid, alpha-galactosylceramide (alpha-GalCer), known to selectively activate Valpha14 NKT cells in the context of CD1d molecules, was administered to sporozoite-inoculated mice. The administration of alpha-GalCer resulted in rapid, strong antimalaria activity, inhibiting the development of the intrahepatocytic stages of the rodent malaria parasites Plasmodium yoelii and Plasmodium berghei. The antimalaria activity mediated by alpha-GalCer is stage-specific, since the course of blood-stage-induced infection was not inhibited by administration of this glycolipid. Furthermore, it was determined that IFN-gamma is essential for the antimalaria activity mediated by the glycolipid. Taken together, our results provide the clear evidence that NKT cells can mediate protection against an intracellular microbial infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10900007      PMCID: PMC26970          DOI: 10.1073/pnas.97.15.8461

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  CD8(+)NKR-P1A (+)T cells preferentially accumulate in human liver.

Authors:  S Ishihara; M Nieda; J Kitayama; T Osada; T Yabe; Y Ishikawa; H Nagawa; T Muto; T Juji
Journal:  Eur J Immunol       Date:  1999-08       Impact factor: 5.532

2.  IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses.

Authors:  J Magram; S E Connaughton; R R Warrier; D M Carvajal; C Y Wu; J Ferrante; C Stewart; U Sarmiento; D A Faherty; M K Gately
Journal:  Immunity       Date:  1996-05       Impact factor: 31.745

3.  Drug resistant Plasmodium vivax malaria.

Authors:  M Whitby
Journal:  J Antimicrob Chemother       Date:  1997-12       Impact factor: 5.790

Review 4.  Mouse NK1.1+ T cells: a new family of T cells.

Authors:  A P Vicari; A Zlotnik
Journal:  Immunol Today       Date:  1996-02

5.  CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.

Authors:  T Kawano; J Cui; Y Koezuka; I Toura; Y Kaneko; K Motoki; H Ueno; R Nakagawa; H Sato; E Kondo; H Koseki; M Taniguchi
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

6.  The large difference in infectivity for mice of Plasmodium berghei and Plasmodium yoelii sporozoites cannot be correlated with their ability to enter into hepatocytes.

Authors:  M R Briones; M Tsuji; V Nussenzweig
Journal:  Mol Biochem Parasitol       Date:  1996-04       Impact factor: 1.759

7.  Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000.

Authors:  R Nakagawa; K Motoki; H Ueno; R Iijima; H Nakamura; E Kobayashi; A Shimosaka; Y Koezuka
Journal:  Cancer Res       Date:  1998-03-15       Impact factor: 12.701

Review 8.  Primaquine resistance in Plasmodium vivax.

Authors:  W E Collins; G M Jeffery
Journal:  Am J Trop Med Hyg       Date:  1996-09       Impact factor: 2.345

9.  Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.

Authors:  N Burdin; L Brossay; Y Koezuka; S T Smiley; M J Grusby; M Gui; M Taniguchi; K Hayakawa; M Kronenberg
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

10.  alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.

Authors:  K J Hammond; L D Poulton; L J Palmisano; P A Silveira; D I Godfrey; A G Baxter
Journal:  J Exp Med       Date:  1998-04-06       Impact factor: 14.307

View more
  88 in total

1.  NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor beta, and by clonally deleting antigen-specific T cells.

Authors:  Hyun Jung Kim; Su Jin Hwang; Byoung Kwon Kim; Kyeong Cheon Jung; Doo Hyun Chung
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell.

Authors:  Joyce Rauch; Jenny Gumperz; Cheryl Robinson; Markus Sköld; Chris Roy; David C Young; Michel Lafleur; D Branch Moody; Michael B Brenner; Catherine E Costello; Samuel M Behar
Journal:  J Biol Chem       Date:  2003-09-08       Impact factor: 5.157

Review 3.  Role of CD1d-restricted NKT cells in microbial immunity.

Authors:  Markus Sköld; Samuel M Behar
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

4.  Alpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection.

Authors:  Isabel Sada-Ovalle; Markus Sköld; Tian Tian; Gurdyal S Besra; Samuel M Behar
Journal:  Am J Respir Crit Care Med       Date:  2010-05-27       Impact factor: 21.405

Review 5.  Induced pluripotency as a potential path towards iNKT cell-mediated cancer immunotherapy.

Authors:  Hiroshi Watarai; Daisuke Yamada; Shin-ichiro Fujii; Masaru Taniguchi; Haruhiko Koseki
Journal:  Int J Hematol       Date:  2012-05-17       Impact factor: 2.490

Review 6.  Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvant.

Authors:  Neal N Padte; Xiangming Li; Moriya Tsuji; Sandhya Vasan
Journal:  Clin Immunol       Date:  2010-12-24       Impact factor: 3.969

Review 7.  V alpha14 i NKT cells are innate lymphocytes that participate in the immune response to diverse microbes.

Authors:  Yuki Kinjo; Mitchell Kronenberg
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

8.  Human cytomegalovirus (HCMV) US2 protein interacts with human CD1d (hCD1d) and down-regulates invariant NKT (iNKT) cell activity.

Authors:  Jihye Han; Seung Bae Rho; Jae Yeon Lee; Joonbeom Bae; Se Ho Park; Suk Jun Lee; Sang Yeol Lee; Curie Ahn; Jae Young Kim; Taehoon Chun
Journal:  Mol Cells       Date:  2013-11-08       Impact factor: 5.034

9.  Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus.

Authors:  J A Hobbs; S Cho; T J Roberts; V Sriram; J Zhang; M Xu; R R Brutkiewicz
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Exacerbation of invasive Candida albicans infection by commensal bacteria or a glycolipid through IFN-γ produced in part by iNKT cells.

Authors:  Norihito Tarumoto; Yuki Kinjo; Naoki Kitano; Daisuke Sasai; Keigo Ueno; Akiko Okawara; Yuina Izawa; Minoru Shinozaki; Hiroshi Watarai; Masaru Taniguchi; Haruko Takeyama; Shigefumi Maesaki; Kazutoshi Shibuya; Yoshitsugu Miyazaki
Journal:  J Infect Dis       Date:  2013-10-04       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.